Détail du document
Identifiant

oai:arXiv.org:2408.04831

Sujet
Computer Science - Computer Vision... Computer Science - Artificial Inte...
Auteur
Du, Bi'an Meng, Lingbei Hu, Wei
Catégorie

Computer Science

Année

2024

Date de référencement

08/01/2025

Mots clés
sparse inputs model images computer 3d
Métrique

Résumé

Sparse-view 3D reconstruction is a major challenge in computer vision, aiming to create complete three-dimensional models from limited viewing angles.

Key obstacles include: 1) a small number of input images with inconsistent information; 2) dependence on input image quality; and 3) large model parameter sizes.

To tackle these issues, we propose a self-augmented two-stage Gaussian splatting framework enhanced with structural masks for sparse-view 3D reconstruction.

Initially, our method generates a basic 3D Gaussian representation from sparse inputs and renders multi-view images.

We then fine-tune a pre-trained 2D diffusion model to enhance these images, using them as augmented data to further optimize the 3D Gaussians.

Additionally, a structural masking strategy during training enhances the model's robustness to sparse inputs and noise.

Experiments on benchmarks like MipNeRF360, OmniObject3D, and OpenIllumination demonstrate that our approach achieves state-of-the-art performance in perceptual quality and multi-view consistency with sparse inputs.

Du, Bi'an,Meng, Lingbei,Hu, Wei, 2024, AugGS: Self-augmented Gaussians with Structural Masks for Sparse-view 3D Reconstruction

Document

Ouvrir

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced